Evan Hecker

Vice President, Head Of CMC Development at PepGen

Evan Hecker is an accomplished professional in the pharmaceutical and biotechnology sectors, currently serving as Vice President and Head of CMC Development at PepGen. With extensive experience in CMC leadership roles, Evan has held positions including Senior Vice President and Head of CMC at Ikena Oncology, Vice President and Head of CMC at Spero Therapeutics, and Senior Director of API Development. Previous experience includes serving as Director of Process Chemistry at Karyopharm Therapeutics Inc. Evan's academic background includes a Doctor of Philosophy in Organic Chemistry from The University of Texas at Austin and a Bachelor of Science in Chemistry from The College of New Jersey.

Location

Boston, United States

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices


PepGen

2 followers

Driven by its proprietary Enhanced Delivery Oligonucleotide (EDO) platform, PepGen is creating a pipeline of disease-modifying therapeutics with the potential to safely and effectively target the root cause of serious genetic diseases, with an initial focus on neuromuscular diseases.


Industries

Employees

11-50

Links